Companies: 10,795·Total market cap: $144.5T
VectivBio Holding AG

VectivBio Holding AG

VECTNASDAQHealthcare
$16.87
+$0.02(+0.12%)
Market Cap$1.1B
P/E Ratio—
52W High$16.98
52W Low$4.25
Overview
Foreign Private Issuer · Files 20-F / 6-K

VectivBio Holding AG (VECT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001836379 · VECT · NASDAQ · as of Jun 9, 2026

Filing snapshot

121
Total Filings
SC 13G/A
Latest Form
2024-02-14
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001836379 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2023-04-19
Fiscal Year End
Apr 19, 2023
Accession No.
0000950170-23-013373
Primary Document
vect-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001836379 · Accession 0000950170-23-013373

Latest Key Filings

6-KQuarterly Report
6-K
2023-07-17
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-02-14
View
15-12G15-12G
15-12G
2023-07-25
View
EFFECTEFFECT
EFFECT
2023-07-21
View
EFFECTEFFECT
EFFECT
2023-07-21
View
EFFECTEFFECT
EFFECT
2023-07-21
View
POS AMPOS AM
POS AM
2023-07-20
View
POS AMPOS AM
POS AM
2023-07-20
View
POS AMPOS AM
POS AM
2023-07-20
View
S-8 POSS-8 POS
S-8 POS
2023-07-20
View
S-8 POSS-8 POS
S-8 POS
2023-07-20
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-07-17
View
2525
25
2023-07-10
View
SC 13DActivist Ownership Report
SC 13D
2023-07-07
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2023-06-29
View
6-KCurrent Report (Foreign Issuer)
6-K
2023-06-29
View
Showing 1–15 of 121 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001836379  |  Exchange: NASDAQ · Healthcare

VectivBio Holding AG (NASDAQ: VECT) has submitted 121 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001836379, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is VectivBio Holding AG's most comprehensive regulatory disclosure. The most recent VectivBio Holding AG 10-K was filed on 2023-04-19 for fiscal year ending 2023. Historical VECT 10-K annual reports are available from 2020 through 2023.

Investors researching VectivBio Holding AG SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
CTIC SEC Filings →EQRX SEC Filings →VERV SEC Filings →PSTX SEC Filings →ALBO SEC Filings →CMRX SEC Filings →CBIO SEC Filings →ETHZ SEC Filings →
→ VECT Financials→ VECT Earnings→ VECT Insider Trades

Frequently Asked Questions

VECT SEC Filings · 8 questions

VectivBio Holding AG (VECT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 121 filings and access original documents at no cost. VectivBio Holding AG's CIK is 0001836379.

VECT SEC filingsVectivBio Holding AG SEC documentsfind VECT 10-K